Avalyn Pharma Inc. (AVLN) stock
Close on Nov 13, 2026Market cap $1.34BP/E –Yield –
Avalyn Pharma statistics
39 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 3.63
- 2.22
Share statisticsIndustry
- Shares Change (QoQ)
- 0.13%
- 0.50%
- Float
- 30M
- 49M
- Shares Held by Insiders
- 32.6%
- 11.7%
- Shares Held by Institutions
- 99.3%
- 56.4%
Short sellingIndustry
- Short Interest
- 2M
- –
- Short Interest Change
- -2.21%
- -0.80%
- Short % of Float
- 7.70%
- 9.01%
- Short % of Shares Outstanding
- 5.19%
- 6.30%
- Days to Cover
- 5.30
- 5.15
Stock price statisticsIndustry
- 20-Day Moving Average
- $27.26
- –
- 50-Day Moving Average
- $28.66
- –
- Average True Range (14)
- $2.02
- –
- Price Change (1 Week)
- 3.88%
- -1.15%
- Price Change (1 Month)
- 22.9%
- -4.87%
- Price Change (3 Months)
- -20.8%
- -21.0%
- Price Change (6 Months)
- 1.47%
- -20.6%
- Average Volume (10 Days)
- 528,139
- –
- Average Volume (20 Days)
- 494,548
- –
- Average Volume (90 Days)
- 301,253
- –
- Relative Volume
- 1.93
- 0.70
- Relative Strength Index (14)
- 59.9
- 43.4
- Volatility (1 Year)
- 64.0%
- 80.1%
Financial positionIndustry
- Current Ratio
- 25.76
- 3.30
- Quick Ratio
- 25.28
- 2.39
- Debt / Equity
- 0.04
- 0.49
Balance sheetIndustry
- Net Cash (Debt)
- $312.64M
- $17.76M
- Net Cash Per Share
- $7.05
- $0.80
- Equity (Book Value)
- $370.25M
- $53.89M
- Book Value Per Share
- $8.35
- $1.50
- Tangible Book Value
- $370.25M
- $27.13M
- Working Capital
- $320.75M
- $79.99M
Scores and fair valueIndustry
- Altman Z-Score
- 27.46
- 0.23
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | AVLN | S&P 500 | Difference | AVLN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +27.5% | -3.0% | +30.6 pts | ||
| 3 months | -17.2% | -2.8% | −14.4 pts | ||
| Year to date | +302700.0% | +11.5% | +302688.5 pts | ||
| 1 year | +302700.0% | +13.5% | +302686.5 pts | ||
| 3 years | +302700.0% | +77.7% | +302622.3 pts | +1346.7% | +21.1% |
| 5 years | +302700.0% | +72.6% | +302627.4 pts | +396.9% | +11.5% |
| 10 years | +302700.0% | +308.2% | +302391.8 pts | +122.9% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
2M AVLN shares were sold short on Oct 30, 2026, down 2.2% from the previous report, or 7.70% of the shares available to trade. At recent volumes it would take 5.3 days to buy them back. Over the last 20 sessions, 70.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 2,302,218 | -2.2% | 434,319 | 5.3 |
| Oct 15, 2026 | 2,354,271 | -6.4% | 355,244 | 6.6 |
| Sep 30, 2026 | 2,516,254 | +20.2% | 295,206 | 8.5 |
| Sep 15, 2026 | 2,093,252 | +8.4% | 218,924 | 9.6 |
| Aug 31, 2026 | 1,930,246 | -6.9% | 170,146 | 11.3 |
| Aug 14, 2026 | 2,072,596 | +2.7% | 189,679 | 10.9 |
| Jul 31, 2026 | 2,018,998 | -7.8% | 215,736 | 9.4 |
| Jul 15, 2026 | 2,190,330 | +1.1% | 389,906 | 5.6 |
| Jun 30, 2026 | 2,165,545 | +65.4% | 704,258 | 3.1 |
| Jun 15, 2026 | 1,309,105 | +46.1% | 236,671 | 5.5 |
| May 29, 2026 | 896,139 | +59.3% | 278,129 | 3.2 |
| May 15, 2026 | 562,374 | – | 416,629 | 1.4 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?